FDA authorizes Merck’s pill to treat covid-19, giving U.S. a second easy-to-use drug
Published
Merck's anti-covid pill, molnupiravir, was authorized by federal regulators a day after Pfizer's pill received a green light. Molnupiravir carries risks, but with treatments in short supply, it may be the only option available.
Full Article